Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anterix (ATEX) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Anterix (ATEX) over the last 12 years, with Q4 2025 value amounting to $181.1 million.

  • Anterix's Total Liabilities fell 48.48% to $181.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $181.1 million, marking a year-over-year decrease of 48.48%. This contributed to the annual value of $176.5 million for FY2025, which is 771.44% up from last year.
  • According to the latest figures from Q4 2025, Anterix's Total Liabilities is $181.1 million, which was down 48.48% from $180.0 million recorded in Q3 2025.
  • Anterix's 5-year Total Liabilities high stood at $181.9 million for Q4 2024, and its period low was $38.9 million during Q2 2021.
  • Its 5-year average for Total Liabilities is $122.2 million, with a median of $101.3 million in 2023.
  • Its Total Liabilities has fluctuated over the past 5 years, first surged by 32112.72% in 2021, then tumbled by 48.48% in 2025.
  • Anterix's Total Liabilities (Quarter) stood at $92.4 million in 2021, then rose by 6.66% to $98.6 million in 2022, then surged by 50.76% to $148.6 million in 2023, then increased by 22.42% to $181.9 million in 2024, then dropped by 0.48% to $181.1 million in 2025.
  • Its last three reported values are $181.1 million in Q4 2025, $180.0 million for Q3 2025, and $174.8 million during Q2 2025.